Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3341-6
Published Online: 2017-05-23
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hirooka, Yoshiki
Ishikawa, Takuya
Kawashima, Hiroki
Ohno, Eizaburo
Nonogaki, Koji
Kanamori, Akira
Hirai, Takanori
Uchida, Hiroki
Shirai, Osamu
Ishikawa, Hideki
Goto, Hidemi
License valid from 2017-05-23